Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10
about
Interferon-λ: Immune Functions at Barrier Surfaces and BeyondMurine Herc6 Plays a Critical Role in Protein ISGylation In Vivo and Has an ISGylation-Independent Function in Seminal Vesicles.USP18 Sensitivity of Peptide Transporters PEPT1 and PEPT2.Mice null for the deubiquitinase USP18 spontaneously develop leiomyosarcomasSuppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling.Genetic inhibition of JNK3 ameliorates spinal muscular atrophy.Tensor decomposition for multiple-tissue gene expression experimentsConcerted action of IFN-α and IFN-λ induces local NK cell immunity and halts cancer growth.Investigations of interferon-lambda for the treatment of cancer.STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling.Targeting IFN-λ: therapeutic implications.IFN-λ cancer immunotherapy: new kid on the block.Multiple functions of USP18.Contribution of type III interferons to antiviral immunity: location, location, location.SOCS1 is an inducible negative regulator of IFN lambda induced gene expression in vivo.Pharmacological DNA demethylation: Implications for cancer immunotherapy.Identification of differentially expressed genes in human breast cancer cells induced by 4-hydroxyltamoxifen and elucidation of their pathophysiological relevance and mechanisms.Evidence for the ISG15-Specific Deubiquitinase USP18 as an Antineoplastic Target.USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity.Targeting DNA Methyltranferases in Urological Tumors.
P2860
Q26801049-F8F39956-8517-4CE3-8242-C457BC0F2474Q35589788-7E6579E4-65D1-46E6-A4D0-41313E814AE0Q35654199-3848D49F-DADB-4CD0-9EBE-4044760B222AQ35837348-9EFE831B-58CD-47AB-A7CA-41F8D8D18D61Q36030376-3C35FC8F-CF23-428D-B171-E909633210F3Q36302096-97C459DE-760F-401E-B984-FEB0DB2C7BA0Q37229738-F4E7ADB8-5663-4076-9455-9528805A10D7Q37580211-BCBD971C-1737-431E-8B7F-0CBD29899DFEQ38347596-E9CD1070-C60C-4435-92C3-D89206C9FD08Q38717767-ADB5C68F-2196-4120-A6D0-A219F546D81BQ38816811-CEECDEF4-49BF-4003-9C36-BBF105ABDF5FQ38887297-897D3FEC-2230-44E0-8AAB-19DBE959307FQ38997388-7B83F8A7-346B-44D7-9166-1FABF2813772Q39176570-2A635043-FC27-4395-99CD-EB9FF17BBD8CQ40044687-6376F46E-C444-4984-B7C2-6F9814F797B9Q40438472-FEF2D272-50A7-4E00-A5A3-3F288AFB0519Q49412994-8D7239F3-AA55-46B8-82BA-0EB50871E7A8Q49990366-036323EF-A46F-47FA-A142-CCABB4DF11E1Q50884645-CDF187D4-00BE-4AF1-ADAD-BB992DDE1A3CQ55435258-F86A6119-C011-4D42-A2CA-397E15797392
P2860
Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Usp18 deficient mammary epithe ...... d elevated secretion of Cxcl10
@en
Usp18 deficient mammary epithe ...... elevated secretion of Cxcl10.
@nl
type
label
Usp18 deficient mammary epithe ...... d elevated secretion of Cxcl10
@en
Usp18 deficient mammary epithe ...... elevated secretion of Cxcl10.
@nl
prefLabel
Usp18 deficient mammary epithe ...... d elevated secretion of Cxcl10
@en
Usp18 deficient mammary epithe ...... elevated secretion of Cxcl10.
@nl
P2093
P2860
P356
P1476
Usp18 deficient mammary epithe ...... d elevated secretion of Cxcl10
@en
P2093
Christoph Burkart
Dong-Er Zhang
Kei-ichiro Arimoto
Lesley G Ellies
Nengming Xiao
Sergei V Kotenko
Tingdong Tang
Xiuli Cong
Yun-Cai Liu
P2860
P304
P356
10.1002/EMMM.201201864
P577
2013-05-16T00:00:00Z